BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 28, 2022
View Archived Issues
Nektar Therapeutics presents preclinical data on NKTR-255
Read More
KSHN-001034, a novel prodrug that delivers higher fulvestrant concentrations
Read More
BLU-222 shows efficacy in CCNE1-amplified ovarian cancer models
Read More
Chinese researchers divulge new compounds for cancer
Read More
New YAP1/TEAD interaction inhibitors disclosed by SpringWorks Therapeutics and collaborators
Read More
Humanwell Healthcare presents new P2X3 receptor antagonists
Read More
University of Texas System identifies CBP and/or p300 inhibitors
Read More
Medy-Tox patents new BTK inhibitors
Read More
Herantis reports blood-brain barrier penetration data with HER-096 in dogs
Read More
AT-0174 IDO/TDO dual inhibitor shows promise for treating platinum-resistant NSCLC
Read More
Allogeneic NK-cell therapy CAT-179 useful for controlling HER2-positive tumors
Read More
Study finds targets of T-cell response in multiple sclerosis
Read More